The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Abstract
During 1988-1989 two highly distinct antigenic variants of influenza type B were recognized in hemagglutination-inhibition tests with postinfection ferret serum. These viruses were antigenically related to either B/Victoria/2/87, the most recent reference strain, or B/Yamagata/16/88, a variant that was isolated in Japan in May 1988. All influenza B viruses isolated in the United States during an epidemic in the winter of 1988-1989 were antigenically related to B/Victoria/2/87. However, in several countries in Asia, both B/Victoria/2/87-like viruses and B/Yamagata/16/88-like viruses were isolated. Sequence analysis of the hemagglutinin (HA) genes of several influenza B isolates from 1987 to 1988 indicated that the HA1 domains of the B/Yamagata/16/88-like viruses and B/VI/87-like viruses isolated in 1988 differed by 27 amino acids. Evolutionary relationships based on this sequence data indicated that the B/Yamagata/16/88-like viruses were more closely related to epidemic viruses from 1983 (B/USSR/100/83-like viruses) than to more recent reference strains such as B/Victoria/2/87. All other Asian strains, as well as selected isolates from the United States in 1988, were confirmed by sequence analysis as being genetically related to B/Victoria/2/87. These data provide clear evidence that two parallel evolutionary pathways of influenza type B have existed since at least 1983 and that viruses from each of the separate lineages were isolated from cases of influenza B in 1988. This finding is similar to earlier observations for type A H1N1 and H3N2 influenza viruses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The time from onset to death observed with fatal influenza B was more rapid than the duration of fatal illness described for pandemic 1918 A(H1N1), pandemic 1957 A(H2N2), pandemic 1968 A(H3N2), pandemic 2009 H1N1, and seasonal A(H3N2) viruses [3, 10-13, 4).”
From Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection (2012) · cites this paper as [4]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036
Both, G. W., Sleigh, M. J., Cox, N. J., & Kendal, A. P. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.52-60.1983 · Cited by 327
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 327
Evidence for host-cell selection of influenza virus antigenic variants
Schild, G. C., OXFORD, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314
Evolution of Human Influenza A Viruses Over 50 Years: Rapid, Uniform Rate of Change in NS Gene
Buonagurio, D. A., Nakada, S., Parvin, J. D., Krystal, M., Palese, P., & Fitch, W. M. (1986) · Science · doi:10.1126/science.2939560 · Cited by 288
Differences in RNA patterns of influenza A viruses
Palese, P., & Schulman, J. L. (1976) · Journal of Virology · doi:10.1128/jvi.17.3.876-884.1976 · Cited by 223
Research works printed but not linked: 1
- World Health Organization, 1989, Recommended composition of influenza virus vaccine for use in the 1989–1990 season, WHO Weekly Epidemiol Rec., 8, 53
Cited by
Sorted by citations
Items 101–200 of 540
Antigenic waves of virus–immune coevolution
Marchi, J., Lässig, M., Walczak, A. M., & Mora, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103398118 · Cited by 62
Chan, P. K. S., Chan, M. C. W., Cheung, J. L. K., Lee, N. L. S., Leung, T. F., Yeung, A. C. M., Wong, M. C. S., Ngai, K. L. K., Nelson, E. A. S., & Hui, D. S. C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis885 · Cited by 61
Labella, A. M., & Merel, S. E. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.03.001 · Cited by 61
Tropism of influenza B viruses in human respiratory tract explants and airway organoids
Bui, C. H. T., Chan, R. W. Y., Ng, M. M. T., Cheung, M.-C., Ng, K., Chan, M. P. K., Chan, L., Fong, J. H. M., Nicholls, J. M., Peiris, M. J. S., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00008-2019 · Cited by 58
Phylodynamic theory of persistence, extinction and speciation of rapidly adapting pathogens
Yan, L. W., Neher, R. A., & Shraiman, B. I. (2019) · eLife · doi:10.7554/elife.44205 · Cited by 61
Antigenic characterization of influenza and SARS-CoV-2 viruses
Wang, Y., Tang, C. Y., & Wan, X. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03806-6 · Cited by 62
Pépin, S., Dupuy, M., Borja-Tabora, C., Montellano, M., Bravo, L. C., Santos, J., de Castro, J.-A., Rivera-Medina, D. M., Cutland, C., Ariza, M., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.11.074 · Cited by 60
Antigenic Variation in Influenza Viruses
Webster, R. G. (1999) · Elsevier eBooks · doi:10.1016/b978-012220360-2/50015-5 · Cited by 61
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
Vogel, O. A., & Manicassamy, B. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00135 · Cited by 60
Subtyping of the Influenza Virus by High Resolution Mass Spectrometry
Schwahn, A. B., Wong, J. W. H., & Downard, K. M. (2009) · Analytical Chemistry · doi:10.1021/ac900026f · Cited by 59
Fulvini, A. A., Manojkumar, R., Le, J., Pokorny, B. A., Arroyo, J. M., Silverman, J., Devis, R., & Bucher, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020823 · Cited by 58
Cox, N. J., & Fukuda, K. (1998) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70406-2 · Cited by 57
Diversifying selective pressure on influenza B virus hemagglutinin
Shen, J., Kirk, B. D., Ma, J., & Wang, Q. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21335 · Cited by 56
Ray, R., Santos, G. D., Buck, P. O., Claeys, C., Matias, G., Innis, B. L., & Bekkat-Berkani, R. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1313375 · Cited by 57
Rosu, M. E., Lexmond, P., Bestebroer, T. M., Hauser, B. M., Smith, D. J., Herfst, S., & Fouchier, R. A. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211616119 · Cited by 55
Clinical Features of Children Infected With Different Strains of Influenza B in Southern Taiwan
Chi, C., Wang, S.-M., Lin, C.-C., Wang, H., Wang, J., Su, I., & Liu, C. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31816be008 · Cited by 55
Okomo‐Adhiambo, M., Sleeman, K., Lysén, C., Nguyen, H., Xu, X., Li, Y., Klimov, A. I., & Gubareva, L. V. (2013) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12113 · Cited by 55
Iminosugars: Promising therapeutics for influenza infection
Tyrrell, B. E., Sayce, A. C., Warfield, K. L., Miller, J. L., & Zitzmann, N. (2016) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1242868 · Cited by 54
Camilloni, B., Neri, M., Lepri, E., & Iorio, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.078 · Cited by 52
van de Sandt, C. E., Dou, Y., Trierum, S. E. V.-V., Westgeest, K. B., Pronk, M., Osterhaus, A. D. M. E., Fouchier, R. A. M., Rimmelzwaan, G. F., & Hillaire, M. L. B. (2015) · Journal of General Virology · doi:10.1099/vir.0.000156 · Cited by 51
Endo, A., Pecoraro, R., Sugita, S., & Nerome, K. (1992) · Archives of Virology · doi:10.1007/bf01317139 · Cited by 51
Exploration of the emergence of the Victoria lineage of influenza B virus
Chen, J., Guo, Y.-J., Wu, K., Guo, J. F., Wang, M., Dong, J., Zhang, Y., Li, Z., & Shu, Y. (2006) · Archives of Virology · doi:10.1007/s00705-006-0852-6 · Cited by 50
Phipps, K. L., Marshall, N., Tao, H., Danzy, S., Onuoha, N., Steel, J., & Lowen, A. C. (2017) · Journal of Virology · doi:10.1128/jvi.00830-17 · Cited by 50
Selection of influenza vaccine strains and developing pandemic vaccines
Wood, J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00509-1 · Cited by 50
Elster, C., Fourest, E., Baudin, F., Larsen, K., Cusack, S., & Ruigrok, R. W. H. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-1-37 · Cited by 50
Eichner, M., Schwehm, M., Hain, J., Uphoff, H., Salzberger, B., Knuf, M., & Schmidt‐Ott, R. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-365 · Cited by 50
Wang, Y., Chang, C., Chi, C., Wang, H., Wang, J., & Su, I. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23219 · Cited by 49
Puzelli, S., Martino, A. D., Facchini, M., Fabiani, C., Calzoletti, L., Mario, G. D., Palmieri, A., Affanni, P., Camilloni, B., Chironna, M., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4621-z · Cited by 49
Skowronski, D. M., Hamelin, M., Janjua, N. Z., Serres, G. D., Gardy, J. L., Rhéaume, C., Bouhy, X., & Boivin, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038929 · Cited by 48
Skowronski, D. M., Chambers, C., Serres, G. D., Sabaiduc, S., Winter, A., Dickinson, J. A., Gubbay, J. B., Drews, S. J., Fonseca, K., Charest, H., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy876 · Cited by 48
Chi, X., Bolar, T. V., Zhao, P., Rappaport, R., & Cheng, S. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5770-5773.2003 · Cited by 48
Effector mechanisms of influenza-specific antibodies: neutralization and beyond
Sicca, F., Neppelenbroek, S., & Huckriede, A. L. W. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1516553 · Cited by 47
Henritzi, D., Hoffmann, B., Wacheck, S., Pesch, S., Herrler, G., Beer, M., & Harder, T. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12613 · Cited by 47
Tewawong, N., Suwannakarn, K., Prachayangprecha, S., Korkong, S., Vichiwattana, P., Vongpunsawad, S., & Poovorawan, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116302 · Cited by 46
Recent progress in chemical approaches for the development of novel neuraminidase inhibitors
Mahal, A., Duan, M., Zinad, D. S., Mohapatra, R. K., Obaidullah, A. J., Wei, X., Pradhan, M. K., Das, D., Kandi, V., Zinad, H. S., et al. (2021) · RSC Advances · doi:10.1039/d0ra07283d · Cited by 46
Matsuzaki, Y., Sugawara, K., Takashita, E., Muraki, Y., Hongo, S., Katsushima, N., Mizuta, K., & Nishimura, H. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20156 · Cited by 46
Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013
on behalf of the GROG network, Mosnier, A., Caini, S., Daviaud, I., Bensoussan, J.-L., Stoll‐Keller, F., Bui, T. T., Lina, B., van der Werf, S., & Cohen, J. M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1056-z · Cited by 44
Greenberg, D. P., Robertson, C. A., Landolfi, V. A., Bhaumik, A., Senders, S. D., & Decker, M. D. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000254 · Cited by 43
Cross-reactive antibodies induced by a monovalent influenza B virus vaccine
Levandowski, R. A., Gross, P. A., Weksler, M. E., Staton, E., Williams, M. S., & Bonelli, J. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.7.1530-1532.1991 · Cited by 43
Baras, B., Cam, N. L., Devaster, J., Fries, L. F., Gillard, P. H., Sänger, R., & Hanon, E. (2008) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2008.00054.x · Cited by 42
Prospects of HA-Based Universal Influenza Vaccine
Hashem, A. M. (2015) · BioMed Research International · doi:10.1155/2015/414637 · Cited by 43
Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households
Xu, C., Chan, K., Tsang, T. K., Fang, V. J., Fung, R. O. P., Ip, D., Cauchemez, S., Leung, G. M., Peiris, M. J. S., & Cowling, B. J. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv110 · Cited by 42
Wu, C., Cheng, X., He, J., Lv, X., Wang, J., Deng, R., Long, Q., & Wang, X. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.10.023 · Cited by 41
Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases
Vieira, M. C., Donato, C. M., Arevalo, P., Rimmelzwaan, G. F., Wood, T., Lopez, L. D., Huang, Q. S., Vijaykrishna, D., Koelle, K., & Cobey, S. E. (2021) · Nature Communications · doi:10.1038/s41467-021-24566-y · Cited by 38
de Vries, R. D., Nieuwkoop, N. J., van der Klis, F. R. M., Koopmans, M. P. G., Krammer, F., & Rimmelzwaan, G. F. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix546 · Cited by 39
Real-time RT-PCR assays for discriminating influenza B virus Yamagata and Victoria lineages
Nakauchi, M., Takayama, I., Takahashi, H., Oba, K., Kubo, H., Kaida, A., Tashiro, M., & Kageyama, T. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.04.016 · Cited by 39
Cioppa, G. D., Vesikari, T., Sokal, E. M., LINDERT, K. A., & Nicolay, U. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.111 · Cited by 39
Diagnostic Microarray for Influenza B Viruses
Dankbar, D. M., Dawson, E. D., Mehlmann, M., Moore, C. L., Smagala, J. A., Shaw, M. W., Cox, N. J., Kuchta, R. D., & Rowlen, K. L. (2007) · Analytical Chemistry · doi:10.1021/ac061960s · Cited by 39
Epidemiology of influenza B in Australia: 2001‐2014 influenza seasons
Moa, A., Muscatello, D. J., Turner, R. M., & MacIntyre, C. R. (2016) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12432 · Cited by 38
Mtambo, S. E., Amoako, D. G., Somboro, A. M., Agoni, C., Lawal, M. M., Gumede, N. S., Khan, R. B., & Kumalo, H. M. (2021) · Molecules · doi:10.3390/molecules26040880 · Cited by 45
Chan, L., Alizadeh, K., Alizadeh, K., Fazel, F., Kakish, J. E., Karimi, N., Knapp, J. P., Mehrani, Y., Minott, J. A., Morovati, S., et al. (2021) · Vaccines · doi:10.3390/vaccines9090979 · Cited by 40
A comprehensive review of influenza B virus, its biological and clinical aspects
Ashraf, M. A., Raza, M. A., Amjad, M., Din, G. U., Yue, L., Shen, B., Chen, L., Wei, D., Xu, H., & Hu, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1467029 · Cited by 42
Epitope-focused vaccine design against influenza A and B viruses
Ren, H., & Zhou, P. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.06.002 · Cited by 37
Yang, J., Huang, Y.-P., Chang, F., Hsu, L., Lin, Y.-C., Huang, H., Wu, F.-T., Wu, H.-S., & Liu, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047179 · Cited by 38
The End of B/Yamagata Influenza Transmission — Transitioning from Quadrivalent Vaccines
Monto, A. S., Zambon, M. C. F. A., & Weir, J. P. (2024) · New England Journal of Medicine · doi:10.1056/nejmp2314801 · Cited by 36
Zhang, Z., Zhang, H., Xu, L., Guo, X. Y., Wang, W., Ji, Y., Lin, C., Wang, Y., & Wang, X. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008989 · Cited by 36
Chen, Y., Aspelund, A., & Jin, H. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.11.013 · Cited by 36
Phylogenetic analysis of the three polymerase genes (PB1, PB2 and PA) of influenza B virus
Hiromoto, Y., Nerome, K., Nerome, R., Lindstrom, S., Saito, T., Sugita, S., Shinjoh, M., & Li, Y. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-4-929 · Cited by 36
Quadrivalent Ann Arbor strain live-attenuated influenza vaccine
Toback, S. L., Levin, M. J., Block, S. L., Belshe, R. B., Ambrose, C. S., & Falloon, J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.108 · Cited by 35
Sun, W., Kang, D. S., Zheng, A., Liu, S. T. H., Broecker, F., Simon, V. R., Krammer, F., & Palese, P. (2018) · Journal of Virology · doi:10.1128/jvi.01673-18 · Cited by 35
Targeting Antigens for Universal Influenza Vaccine Development
Nguyen, Q. T., & Choi, Y. K. (2021) · Viruses · doi:10.3390/v13060973 · Cited by 35
Molecular characterization of the HA gene of influenza type B viruses
Pechirra, P., Nunes, B., Coelho, A., Ribeiro, C., Gonçalves, P., Pedro, S. N., Castro, L. C. E., & Rebelo‐de‐Andrade, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20490 · Cited by 35
Nakagawa, N., Kubota, R., Maeda, A., Nakagawa, T., & Okuno, Y. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3467-3469.2000 · Cited by 35
Gaglani, M., Vasudevan, A., Raiyani, C., Murthy, K., Chen, W., Reis, M. D., Belongia, E. A., McLean, H. Q., Jackson, M. L., Jackson, L. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa102 · Cited by 34
Jambrina, E., Bárcena, J., Uez, O. C., & Portela, A. (1997) · Virology · doi:10.1006/viro.1997.8682 · Cited by 34
Skowronski, D. M., Chambers, C., Serres, G. D., Sabaiduc, S., Winter, A., Dickinson, J. A., Gubbay, J. B., Fonseca, K., Drews, S. J., Charest, H., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix393 · Cited by 32
Vigil, A., Frias‐Staheli, N., Carabeo, T., & Wittekind, M. G. (2020) · Journal of Virology · doi:10.1128/jvi.00052-20 · Cited by 33
Evaluation of Southern Hemisphere influenza vaccine recommendations
Richard, S. A., Viboud, C. G., & Miller, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.053 · Cited by 32
Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses
Borchering, R. K., Gunning, C. E., Gokhale, D. V., Weedop, K. B., Saeidpour, A., Brett, T. S., & Rohani, P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012327118 · Cited by 32
Camilloni, B., Neri, M., Lepri, E., Basileo, M., Sigismondi, N., Puzelli, S., Donatelli, I., & Iorio, A. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.064 · Cited by 32
Puzelli, S., Frezza, F., Fabiani, C., Ansaldi, F., Campitelli, L., Lin, Y. P., Gregory, V., Bennett, M., D’Agaro, P., Campello, C., et al. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20225 · Cited by 32
Hartvickson, R., Cruz, M., Ervin, J. E., Brandon, D. M., Forleo‐Neto, E., Dagnew, A. F., Chandra, R., LINDERT, K. A., & Mateen, A. A. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.11.004 · Cited by 32
Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014
Oong, X. Y., Ng, K. T., Lam, T. T., Pang, Y. K., Chan, K., Hanafi, N. S., Kamarulzaman, A., & Tee, K. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136254 · Cited by 31
Animal Models Utilized for the Development of Influenza Virus Vaccines
Roubidoux, E. K., & Schultz‐Cherry, S. (2021) · Vaccines · doi:10.3390/vaccines9070787 · Cited by 31
M2e-Based Influenza Vaccines with Nucleoprotein: A Review
Tan, M. P., Tan, W. S., Alitheen, N. B., & Yap, W. B. (2021) · Vaccines · doi:10.3390/vaccines9070739 · Cited by 30
Rosario, J. M. M. D., da Costa, K. A. S., Asbach, B., Ferrara, F., Ferrari, M., Wells, D. A., Mann, G. S., Ameh, V. O., Sabeta, C. T., Banyard, A. C., et al. (2021) · Vaccines · doi:10.3390/vaccines9070741 · Cited by 27
When “B” becomes “A”: the emerging threat of influenza B virus
Sharma, L., Rebaza, A. P., & Cruz, C. S. D. (2019) · European Respiratory Journal · doi:10.1183/13993003.01325-2019 · Cited by 30
Horthongkham, N., Athipanyasilp, N., Pattama, A., Kaewnapan, B., Sornprasert, S., Srisurapanont, S., Kantakamalakul, W., Ammaranond, P., & Sutthent, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158244 · Cited by 29
Kim, M. H., Kang, J.-O., Kim, J., Jung, H. E., Lee, H. K., & Chang, J. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.002 · Cited by 29
Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance
Mathew, N. R., & Angeletti, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02997 · Cited by 29
Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000
Barr, I., Komadina, N., Durrant, C. J., Sjogren, H. M., Hurt, A. C., & Shaw, R. P. (2006) · Communicable Diseases Intelligence · doi:10.33321/cdi.2006.30.32 · Cited by 29
Robertson, C. A., Mercer, M., Selmani, A., Klein, N. P., Jeanfreau, R. J., & Greenberg, D. P. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002227 · Cited by 29
Lee, S.-Y., Kang, J.-O., & Chang, J. (2019) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2019.8.1.54 · Cited by 29
Comparison of Pathogenicity and Transmissibility of Influenza B and D Viruses in Pigs
Lee, J., Wang, L., Palinski, R. M., Walsh, T., He, D., Li, Y., Wu, R. J., Lang, Y., Sunwoo, S.-Y., Richt, J. A., et al. (2019) · Viruses · doi:10.3390/v11100905 · Cited by 28
Chen, Y., Aspelund, A., Kemble, G. W., & Jin, H. (2008) · Virology · doi:10.1016/j.virol.2008.08.010 · Cited by 28
Sakurai, A., Takayama, K., Nomura, N., Yamamoto, N., Sakoda, Y., Kobayashi, Y., Kida, H., & Shibasaki, F. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.08.025 · Cited by 29
Fluorescent Immunochromatography for Rapid and Sensitive Typing of Seasonal Influenza Viruses
Sakurai, A., Takayama, K., Nomura, N., Kajiwara, N., Okamatsu, M., Yamamoto, N., Tamura, T., Yamada, J., Hashimoto, M., Sakoda, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116715 · Cited by 28
Hagiwara, Y., Harada, K., Nealon, J., Okumura, Y., Kimura, T., & Chaves, S. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272795 · Cited by 27
Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the ‘loop’
Nakagawa, N., Kubota, R., Nakagawa, T., & Okuno, Y. (2003) · Journal of General Virology · doi:10.1099/vir.0.18756-0 · Cited by 27
Presa, J., Arranz-Herrero, J., Álvarez, L., Rius‐Rocabert, S., Pozuelo, M. J., Lalueza, A., Ochando, J., Bouza, J. M. E., Sanz-Muñoz, I., & Nistal‐Villán, E. (2025) · European Respiratory Review · doi:10.1183/16000617.0144-2024 · Cited by 26
Increasing Appearance of Reassortant Influenza B Virus in Taiwan from 2002 to 2005
Tsai, H., Wang, H., Kiang, D., Huang, S.-W., Kuo, P.-H., Liu, H., Su, I., & Wang, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02694-05 · Cited by 26
Multiple Genotypes of Influenza B Viruses Cocirculated in Taiwan in 2004 and 2005
Chen, G., Shih, S., Hsiao, M.-R., Chang, S., Lin, S.-H., Sun, C.-F., & Tsao, K. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02189-06 · Cited by 26
Epidemiological and Virological Characterization of Influenza B Virus Infections
Sharabi, S., Drori, Y., Micheli, M., Friedman, N., Orzitzer, S., Bassal, R., Glatman‐Freedman, A., Shohat, T., Mendelson, E., Hindiyeh, M. Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161195 · Cited by 26
Pépin, S., Szymański, H., Kobashi, I. A. R., Martínez, S. M. V., González-Zamora, J. F., Brzostek, J., Huang, L., Chiu, C., Chen, P.-Y., Ahonen, A., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1212143 · Cited by 26
Detection and Characterization of New Influenza B Virus Variants in 2002
Chi, X., Hu, A., Bolar, T. V., Al-Rimawi, W., Zhao, P., Tam, J. S., Rappaport, R., & Cheng, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2345-2349.2005 · Cited by 26
Carlock, M. A., & Ross, T. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-43003-2 · Cited by 25
Harvala, H., Smith, D. J., Salvatierra, K. A., Gunson, R. N., von Wissmann, B., Reynolds, A. J., Frew, C. E., MacLean, A., Hunt, A., Yirrell, D., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.37.20903 · Cited by 25
Liu, Y., Strohmeier, S., González‐Domínguez, I., Tan, J., Simon, V. R., Krammer, F., García‐Sastre, A., Palese, P., & Sun, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746447 · Cited by 25
Severe pathogenesis of influenza B virus in pregnant mice
Kim, J. C., Kim, H. M., Kang, Y. M., Ku, K. B., Park, E. H., Yum, J., Kim, J. A., Kang, Y. K., Lee, J. S., Kim, H. S., et al. (2013) · Virology · doi:10.1016/j.virol.2013.10.001 · Cited by 25
Updates on Influenza Vaccination in Children
Campbell, A. J. P., & Grohskopf, L. A. (2018) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.11.005 · Cited by 25
Metadata
- Authors
- Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institute of Health Sciences (JP)
- Corresponding author
- Rota, Paul A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1990-03
- Volume
- 175
- Issue
- 1
- Pages
- 59-68
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1977461039
- Cited by
- 539
- References
- 33
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 22 · 2023: 18 · 2022: 31 · 2021: 32 · 2020: 36 · 2019: 40 · 2018: 41 · 2017: 23 · 2016: 31 · 2015: 30 · 2014: 29 · 2013: 30 · 2012: 14
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Virology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- influenza B, co-circulation, evolutionary lineages, antigenic variants, hemagglutinin gene, hemagglutination inhibition, molecular evolution
- MeSH terms
- Amino Acid Sequence, Antigens, Viral, Base Sequence, Biological Evolution, Genes, Viral, Molecular Sequence Data, Influenza B virus, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review